| # | Side effect | Count |
|---|---|---|
| 0 | DEATH | 1404 |
| 1 | CARDIAC FAILURE | 537 |
| 2 | OFF LABEL USE | 417 |
| 3 | DYSPNOEA | 240 |
| 4 | CARDIAC FAILURE CHRONIC | 194 |
| 5 | PRODUCT USE IN UNAPPROVED INDICATION | 190 |
| 6 | ATRIAL FIBRILLATION | 182 |
| 7 | FATIGUE | 174 |
| 8 | CONDITION AGGRAVATED | 159 |
| 9 | DISEASE PROGRESSION | 146 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | HEREDITARY NEUROPATHIC AMYLOIDOSIS | 15 | 0.2778 |
| 1 | CARDIAC AMYLOIDOSIS | 89 | 0.0808 |
| 2 | CARDIAC FAILURE CHRONIC | 194 | 0.0455 |
| 3 | AMYLOIDOSIS | 40 | 0.0232 |
| 4 | N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED | 26 | 0.0185 |
| 5 | ACQUIRED HAEMOPHILIA | 12 | 0.0120 |
| 6 | LEFT ATRIAL DILATATION | 12 | 0.0094 |
| 7 | LEFT VENTRICULAR HYPERTROPHY | 35 | 0.0082 |
| 8 | CARDIAC FAILURE | 537 | 0.0067 |
| 9 | BRAIN NATRIURETIC PEPTIDE INCREASED | 17 | 0.0055 |